Skip to main content
Erschienen in: Diabetologia 3/2004

01.03.2004 | Article

Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin

verfasst von: T. Nakagami, MD PhD, the DECODA Study Group

Erschienen in: Diabetologia | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The study was done to assess how well fasting and 2-h plasma glucose (FPG, 2-h PG) after a 75-g OGTT predict cardiovascular disease (CVD) and all-cause mortality in Asian subjects.

Methods

People (n=6817) of Japanese and Asian Indian origin from five prospective studies in five countries were monitored for 5 to 10 years. Hazard ratios for death from all causes and CVD were estimated using Cox proportional hazard models, adjusting for FPG, 2-h PG and established risk factors.

Results

Multivariate Cox regression analysis showed that an increase in FPG from 7.0 to 8.0 mmol/l (increase of 0.76 SD) increased relative risk (95% CI) by 1.14 (1.05–1.25) for all-cause and 1.24 (1.10–1.39) for CVD mortality. An increase in 2-h PG from 9.0 to 11.9 mmol/l (0.76 SD) increased relative risks by 1.29 (1.18–1.41) and 1.35 (1.19–1.54). Inclusion of 2-h PG in the FPG model improved the predictive value (p<0.001), whereas FPG did not influence the predictive value of 2-h PG (p>10). In a model containing FPG and 2-h PG, hazards ratios for 2-h PG in subjects with IGT or diabetes were 1.35 (1.03–1.77) or 3.03 (2.18–4.21) for all-cause and 1.27 (0.86–1.88) or 3.39 (2.14–5.37) for CVD mortality, compared with normal subjects. The respective hazards ratio for FPG in subjects with IFG or diabetes were 0.94 (0.68–1.31) or 0.88 (0.59–1.32) for all-cause and 1.05 (0.67–1.65) or 0.88 (0.51–1.51) for CVD mortality, compared with normal subjects.

Conclusions/interpretation

For prediction of premature death, 2-h PG was superior to FPG in several Asian populations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Klein R (1995) Hyperglycemia and microvascular and macrovascular diseases in diabetes. Diabetes Care 18:258–268CrossRefPubMed Klein R (1995) Hyperglycemia and microvascular and macrovascular diseases in diabetes. Diabetes Care 18:258–268CrossRefPubMed
2.
Zurück zum Zitat Turner RC, Millns H, Neil HA et al. (1998) Risk factors for coronary artery disease in non-insulin-dependent diabetes (UKPDS 23). BMJ 316:823–828CrossRefPubMedPubMedCentral Turner RC, Millns H, Neil HA et al. (1998) Risk factors for coronary artery disease in non-insulin-dependent diabetes (UKPDS 23). BMJ 316:823–828CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Kuusisto J, Mykkänen L, Pyörälä K, Laakso M (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960–967CrossRefPubMed Kuusisto J, Mykkänen L, Pyörälä K, Laakso M (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960–967CrossRefPubMed
4.
Zurück zum Zitat Lehto S, Ronnemaa T, Pyörälä K, Laakso M (1996) Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27:63–68CrossRefPubMed Lehto S, Ronnemaa T, Pyörälä K, Laakso M (1996) Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27:63–68CrossRefPubMed
5.
Zurück zum Zitat Standl E, Balletshofer B, Dahl B et al. (1996) Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 39:1540–1545CrossRefPubMed Standl E, Balletshofer B, Dahl B et al. (1996) Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 39:1540–1545CrossRefPubMed
6.
Zurück zum Zitat Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175–1184CrossRefPubMed Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175–1184CrossRefPubMed
7.
Zurück zum Zitat Groeneveld Y, Petri H, Hermans J, Springer MP (1999) Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet Med 16:2–13CrossRefPubMed Groeneveld Y, Petri H, Hermans J, Springer MP (1999) Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet Med 16:2–13CrossRefPubMed
8.
Zurück zum Zitat Stratton IM, Adler AI, Neil HAW et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412CrossRefPubMedPubMedCentral Stratton IM, Adler AI, Neil HAW et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Wei M, Gaskill SP, Haffner SM, Stern MP (1998) Effects of diabetes and level of glycaemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21:1167–1172CrossRefPubMed Wei M, Gaskill SP, Haffner SM, Stern MP (1998) Effects of diabetes and level of glycaemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21:1167–1172CrossRefPubMed
10.
Zurück zum Zitat Hanefeld M, Fischer S, Julius U et al. (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577–1583CrossRefPubMed Hanefeld M, Fischer S, Julius U et al. (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577–1583CrossRefPubMed
11.
Zurück zum Zitat Knuiman MW, Welborn TA, Whittall DE (1992) An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 135:638–648CrossRefPubMed Knuiman MW, Welborn TA, Whittall DE (1992) An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 135:638–648CrossRefPubMed
12.
Zurück zum Zitat Sasaki A, Uehara M, Horiuchi N, Hasegawa K (1983) A long-term follow-up study of diabetic patients in Osaka, Japan: mortality and causes of death. Tohoku J Exp Med 141[Suppl]:639–644 Sasaki A, Uehara M, Horiuchi N, Hasegawa K (1983) A long-term follow-up study of diabetic patients in Osaka, Japan: mortality and causes of death. Tohoku J Exp Med 141[Suppl]:639–644
13.
Zurück zum Zitat Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240CrossRefPubMed Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240CrossRefPubMed
14.
Zurück zum Zitat Pyörälä K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P (1979) Glucose tolerance and coronary heart disease: Helsinki policemen study. J Chronic Dis 32:373–376CrossRef Pyörälä K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P (1979) Glucose tolerance and coronary heart disease: Helsinki policemen study. J Chronic Dis 32:373–376CrossRef
15.
Zurück zum Zitat Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ 287:867–870CrossRefPubMedPubMedCentral Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ 287:867–870CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat De Vegt F, Dekker JM, Ruhe HG et al. (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926–931CrossRef De Vegt F, Dekker JM, Ruhe HG et al. (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926–931CrossRef
17.
Zurück zum Zitat Balkau B, Shipley MJ, Jarrett RJ et al. (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360–367CrossRefPubMed Balkau B, Shipley MJ, Jarrett RJ et al. (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360–367CrossRefPubMed
18.
Zurück zum Zitat Fujishima M, Kiyohara Y, Kato I et al. (1996) Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 45 [Suppl 3]:S14–S16 Fujishima M, Kiyohara Y, Kato I et al. (1996) Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 45 [Suppl 3]:S14–S16
19.
Zurück zum Zitat Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. Diabetes Care 22:920–924CrossRefPubMed Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. Diabetes Care 22:920–924CrossRefPubMed
20.
Zurück zum Zitat Anonymous (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group, European Diabetes Epidemiology Group. Diabetes Epidemiology. Lancet 354:617–621CrossRef Anonymous (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group, European Diabetes Epidemiology Group. Diabetes Epidemiology. Lancet 354:617–621CrossRef
21.
Zurück zum Zitat Anonymous (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. DECODE Study Group, the European Diabetes Epidemiology Group. Arch Intern Med 161:397–405CrossRef Anonymous (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. DECODE Study Group, the European Diabetes Epidemiology Group. Arch Intern Med 161:397–405CrossRef
22.
Zurück zum Zitat King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed
23.
Zurück zum Zitat Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14 [Suppl]:S1–S85 Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14 [Suppl]:S1–S85
24.
Zurück zum Zitat Qiao Q, Nakagami T, Tuomilehto J et al. (2000) Comparison of the fasting and 2-h glucose criteria for diabetes in different Asian cohorts. DECODA Study Group; International Diabetes Epidemiology Group. Diabetologia 43:1470–1475CrossRefPubMed Qiao Q, Nakagami T, Tuomilehto J et al. (2000) Comparison of the fasting and 2-h glucose criteria for diabetes in different Asian cohorts. DECODA Study Group; International Diabetes Epidemiology Group. Diabetologia 43:1470–1475CrossRefPubMed
25.
Zurück zum Zitat Nakagami T, Qiao Q, Tuomilehto J et al. (2002) The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. DECODA Study Group. Diabetes Epidemiology: Collaborative Analysis of Diagnostic criteria in Asia; International Diabetes Epidemiology Group. Diabetes Res Clin Pract 55:35–43CrossRefPubMed Nakagami T, Qiao Q, Tuomilehto J et al. (2002) The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. DECODA Study Group. Diabetes Epidemiology: Collaborative Analysis of Diagnostic criteria in Asia; International Diabetes Epidemiology Group. Diabetes Res Clin Pract 55:35–43CrossRefPubMed
26.
Zurück zum Zitat Anonymous (2002) Cardiovascular risk profile assessment in glucose intolerant Asian individuals—an evaluation of the World Health Organization two-step strategy: the DECODA Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia). Diabet Med 43:549–557 Anonymous (2002) Cardiovascular risk profile assessment in glucose intolerant Asian individuals—an evaluation of the World Health Organization two-step strategy: the DECODA Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia). Diabet Med 43:549–557
27.
Zurück zum Zitat Fujimoto WY, Leonetti DL, Kinyoun JL et al. (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36:721–729CrossRefPubMed Fujimoto WY, Leonetti DL, Kinyoun JL et al. (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36:721–729CrossRefPubMed
28.
Zurück zum Zitat Fujimoto WY, Leonetti DL, Bergstrom RW, Kinyoun JL, Stolov WC, Wahl PW (1991) Glucose tolerance and diabetic complications among Japanese-American women. Diabetes Res Clin Pract 13:119–129CrossRefPubMed Fujimoto WY, Leonetti DL, Bergstrom RW, Kinyoun JL, Stolov WC, Wahl PW (1991) Glucose tolerance and diabetic complications among Japanese-American women. Diabetes Res Clin Pract 13:119–129CrossRefPubMed
29.
Zurück zum Zitat Gimeno SG, Ferreira SR, Franco LJ, Hirai AT, Matsumura L, Moisés RS (2002) Prevalence and 7-year incidence of Type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 45:1635–1638CrossRefPubMed Gimeno SG, Ferreira SR, Franco LJ, Hirai AT, Matsumura L, Moisés RS (2002) Prevalence and 7-year incidence of Type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 45:1635–1638CrossRefPubMed
30.
Zurück zum Zitat Shaw JE, Hodge AM, De Courten M, Chitson P, Zimmet PZ (1999) Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 42:1050–1054CrossRefPubMed Shaw JE, Hodge AM, De Courten M, Chitson P, Zimmet PZ (1999) Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 42:1050–1054CrossRefPubMed
31.
Zurück zum Zitat Dowse GK, Gareeboo H, Alberti KG et al. (1995) Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. BMJ 311:1255–1259CrossRefPubMedPubMedCentral Dowse GK, Gareeboo H, Alberti KG et al. (1995) Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. BMJ 311:1255–1259CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat World Health Organization (1977) The manual of the international statistical classification of diseases, injuries and causes of death, 9th revision. WHO, Geneva World Health Organization (1977) The manual of the international statistical classification of diseases, injuries and causes of death, 9th revision. WHO, Geneva
33.
Zurück zum Zitat World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO, Geneva World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO, Geneva
34.
Zurück zum Zitat Santos Silva I dos (1999) Cancer epidemiology: principles and methods. WHO IARC, Lyon Santos Silva I dos (1999) Cancer epidemiology: principles and methods. WHO IARC, Lyon
35.
36.
Zurück zum Zitat Anonymous (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular disease? DECODE Study Group. European Diabetes Epidemiology Group. Diabetes Care 26:688–696CrossRef Anonymous (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular disease? DECODE Study Group. European Diabetes Epidemiology Group. Diabetes Care 26:688–696CrossRef
37.
Zurück zum Zitat Barrett-Connor E, Ferrarra A (1998) Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care 21:1236–1239CrossRefPubMed Barrett-Connor E, Ferrarra A (1998) Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care 21:1236–1239CrossRefPubMed
38.
Zurück zum Zitat Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M (2000) Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23:1830–1834CrossRefPubMed Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M (2000) Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23:1830–1834CrossRefPubMed
39.
Zurück zum Zitat Kowalska I, Prokop J, Bachorzewska-Gajewska H et al. (2001) Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as a predictor for coronary atherosclerosis. Diabetes Care 24:897–901CrossRefPubMed Kowalska I, Prokop J, Bachorzewska-Gajewska H et al. (2001) Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as a predictor for coronary atherosclerosis. Diabetes Care 24:897–901CrossRefPubMed
40.
Zurück zum Zitat Festa A, D’Agostino Jr R, Tracy RP, Haffner SM (2002) C-reactive protein is more strongly related to post-glucose load than with to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med 19:939–943CrossRefPubMed Festa A, D’Agostino Jr R, Tracy RP, Haffner SM (2002) C-reactive protein is more strongly related to post-glucose load than with to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med 19:939–943CrossRefPubMed
41.
Zurück zum Zitat Festa A, D’Agostino Jr R, Howard G, Mykkänen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42–47CrossRefPubMed Festa A, D’Agostino Jr R, Howard G, Mykkänen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42–47CrossRefPubMed
42.
Zurück zum Zitat Ceriello A (2003) The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 [Suppl 1]:M9–M16 Ceriello A (2003) The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 [Suppl 1]:M9–M16
43.
Zurück zum Zitat Anonymous (1999) Consequence of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabetes Care 22:1667–1671CrossRef Anonymous (1999) Consequence of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabetes Care 22:1667–1671CrossRef
44.
Zurück zum Zitat Pan XR, Li GW, Hu YH et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544CrossRefPubMed Pan XR, Li GW, Hu YH et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544CrossRefPubMed
45.
Zurück zum Zitat Tuomilehto J, Lindström J, Eriksson JG et al. (2001) Prevention of type2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350CrossRefPubMed Tuomilehto J, Lindström J, Eriksson JG et al. (2001) Prevention of type2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350CrossRefPubMed
46.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. N Engl J Med 346:393–403CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. N Engl J Med 346:393–403CrossRefPubMed
47.
Zurück zum Zitat Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM Trial. JAMA 290:486–494CrossRefPubMed Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM Trial. JAMA 290:486–494CrossRefPubMed
48.
Zurück zum Zitat Dyson PA, Hammersley MS, Morris RJ, Holman RR, Turner RC (1997) The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism 46 [Suppl 1]:50–55 Dyson PA, Hammersley MS, Morris RJ, Holman RR, Turner RC (1997) The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism 46 [Suppl 1]:50–55
49.
Zurück zum Zitat Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE (1995) A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18:382–387CrossRefPubMed Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE (1995) A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18:382–387CrossRefPubMed
50.
Zurück zum Zitat Ruige JB, Neeling JN de, Kostense PJ, Bouter LM, Heine RJ (1997) Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 20:491–496CrossRefPubMed Ruige JB, Neeling JN de, Kostense PJ, Bouter LM, Heine RJ (1997) Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 20:491–496CrossRefPubMed
51.
Zurück zum Zitat Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171CrossRefPubMed Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171CrossRefPubMed
52.
Zurück zum Zitat Lindström J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731CrossRefPubMed Lindström J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731CrossRefPubMed
53.
Zurück zum Zitat Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K (2004) A Danish diabetes risk score for targeted screening. Inter 99 (6). Diabetes Care (in press) Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K (2004) A Danish diabetes risk score for targeted screening. Inter 99 (6). Diabetes Care (in press)
54.
Zurück zum Zitat Glümer C, Borch-Johnsen K, Jorgensen T, Colagiuri S (2003) Can screening algorithms for diabetes be applied across populations? Diabetes Metab 29 [Suppl 5]:S22 Glümer C, Borch-Johnsen K, Jorgensen T, Colagiuri S (2003) Can screening algorithms for diabetes be applied across populations? Diabetes Metab 29 [Suppl 5]:S22
Metadaten
Titel
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin
verfasst von
T. Nakagami, MD PhD
the DECODA Study Group
Publikationsdatum
01.03.2004
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 3/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1334-6

Weitere Artikel der Ausgabe 3/2004

Diabetologia 3/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.